About Us

Home About Us
Telum

From Latin origins, Telum is a Proto-Indo-European word for “darts”. Our phage lytic enzymes produced by bacterial viruses degrade specific bonds from peptidoglycan causing massive cell lysis

New weapon in the army of antimicrobials
Telum Therapeutics SL

Is a global drug discovery biotechnology company specializing in the use of Innovative Phage Lytic Proteins as antibiotics (Innobiotics)

Welcome to Telum Therapeutics

Telum Therapeutics SL is a global drug discovery biotechnology company specializing in the use of Innovative Phage Lytic Proteins as antibiotics (Innobiotics).

Since the introduction of antibiotics in the ‘40s, an excessive use of them has been occurred for the treatment of animal and human infections. Over the years, this antibiotics abuse has caused the appearance and spreading of antibiotic resistance in almost all the pathogenic bacteria, some of which are even resistant to all available antibiotics.

Numerous studies place the bacteriophages and, specially, their lytic enzymes, as one of the most promising alternatives to the traditional antibiotics. For this reason, Telum Therapeutics is creating a broad bacteria and phage collection from anthropogenic and cave explorations to obtain new bacteriophages and lytic enzymes with potential antibacterial therapeutic purposes.

Our Mission

Our mission is our commitment and our commitment is our hope in the fight against infections caused by multi-resistant bacteria.
Telum’s mission in the field of antibiotic drug development is to give hope to patients suffering with drug resistant infections by developing new antimicrobial agents.